LENZ Therapeutics (LENZ) Payables: 2022-2023
Historic Payables for Therapeutics (LENZ) over the last 2 years, with Sep 2023 value amounting to $3.8 million.
- Therapeutics' Payables fell 5.51% to $3.8 million in Q3 2023 from the same period last year, while for Sep 2023 it was $11.1 million, marking a year-over-year change of. This contributed to the annual value of $2.6 million for FY2022, which is N/A change from last year.
- According to the latest figures from Q3 2023, Therapeutics' Payables is $3.8 million, which was up 37.98% from $2.7 million recorded in Q2 2023.
- Over the past 5 years, Therapeutics' Payables peaked at $4.0 million during Q3 2022, and registered a low of $2.0 million during Q1 2023.
- For the 2-year period, Therapeutics' Payables averaged around $3.1 million, with its median value being $3.1 million (2022).
- Data for Therapeutics' Payables shows a maximum YoY crashed of 35.09% (in 2023) over the last 5 years.
- Quarterly analysis of 2 years shows Therapeutics' Payables stood at $2.6 million in 2022, then decreased by 5.51% to $3.8 million in 2023.
- Its Payables stands at $3.8 million for Q3 2023, versus $2.7 million for Q2 2023 and $2.0 million for Q1 2023.